1. |
[1]Vogelstein B, Fearon ER, Hamilton SR, Kern SE, Preisinger AC, Leppert M, Nakamura Y, White R, Smits AM, Bos JL. Genetic alterations during colorectal-tumor development[J]. N Engl J Med, 1988; 319 (9): 525-532.
|
2. |
[2]Peipins LA, sandler RS. Epidemiology of colorectal adenomas[J]. Epidemiol Rev, 1994; 16(2):272-297.
|
3. |
[3]Neugut AI, Jacobson JS, DeVivo I. Epidemiology of colorectal adenomatous polyps[J]. Cancer Epidemiol Biomarkers Prev,1993; 2 (2): 159-176.
|
4. |
[4]Winawer SJ, Zauber AG, Ho MN, O’Brien MJ, Gottlieb LS, Sternberg SS, Waye JD, Schapiro M, Bond JH, Panish JF, Jerome D. Waye, Melvin Schapiro, John H. Bond, Joel F. Panish, Ackroyd F, Shike M, Kurtz RC, Hornsby-Lewis L, Gerdes H, Stewart ET, The National Polyp Study Workgroup. Prevention of colorectal cancer by colonoscopic polypectomy[J]. N Engl J Med,1993; 329 (27): 1977-1981.
|
5. |
[5]Janne PA, Mayer RJ. Primary care: Chemoprevention of colorectal cancer[J]. N Engl J Med,2000; 342(26):1960-1968.
|
6. |
[6]Collet JP, Sharpe C, Belzile E, Boivin JF, Hanley J, Abenhaim L. Colorectal cancer prevention by non-steroidal anti-inflammatory drugs: effects of dosage and timing[J]. Br J cancer, 1999; 81 (1): 62-68.
|
7. |
[7]Gao X, Sun S, Sun F, Li M, Sun HB,Zhang WD, Song SQ. Nonsteroidal anti-inflammatory drugs and risk of polyposis, colorectal carcinoma[J]. Chinn J Prev Med, 2002; 36(5):332-335.
|
8. |
高雪芹,孙素玲,孙方利,李敏,孙华宾,张维东,宋守芹. 非甾体类抗炎药对肠息肉及结、直肠癌保护作用的病例对照研究[J]. 中华预防医学杂志, 2002; 36(5):332~335.
|
9. |
[8]Giovannucci E, Rimm EB, Stampfer MJ, Colditz GA, Colditz GA.; Ascherio A; Willett WC. Aspirin Use and the Risk for Colorectal Cancer and adenomas in male health Professionals[J]. Annals of Internal Medicine,1994; 121(4):241-246.
|
10. |
[9]Smalley W, Ray WA, Daugherty J, Griffin MR. Use of nonsteroidal anti-inflammatory drugs and incidence of colorectal cancer: A population-based study[J]. Archives of Internal Medicine, 1999; 159(2):161-166.
|
11. |
[10]Labayle D, Fischer D, Vielh P, Drouhin F, Pariente A, Bories C, Duhamel O, Trousset M, Attali P. Sulindac causes regression of rectal polyps in familial adenomatous polyposis[J]. Gastroenterology, 1991; 101(3):635-639.
|
12. |
[11]Giardiello FM, Hamilton SR, Krush AJ, Piantadosi S, Hylind LM, Celano P, Booker SV, Robinson CR, Offerhaus GJ. Treatment of Colonic and Rectal Adenomas with Sulindac in Familial Adenomatous Polyosis[J]. N Engl J Med, 1993; 328(18):1313-1316.
|
13. |
[12]Baron JA, Cole BF, Sandler RS, Haile RW, Ahnen D, Bresalier R, McKeown-Eyssen G, Summers RW, Rothstein R, Burke CA, Snover DC, Church TR, Allen JI, Beach M, Beck GJ, Bond JH, Byers T, Greenberg ER, Mandel JS, Marcon N, Mott LA, Pearson L, Saibil F, van Stolk RU. A randomized trial of aspirin to prevent colorectal adenomas[J]. N Engl J Med,2003; 348(10):891-899.
|
14. |
[13]Sandler RS, Halabi S, Baron JA, Budinger S, Paskett E, Keresztes R, Petrelli N, Pipas JM, Karp DD, Loprinzi CL, Steinbach G, Schilsky R. A randomized trial of aspirin to prevent colorectal adenomas in patients with provious colorectal cancer[J]. N Engl J Med, 2003; 348(10):883-890.
|
15. |
[14]Benamouzig R, Deyra J, Martin A, Girard B, Jullian E, Piednoir B, Couturier D, Coste T, Little J, Chaussade S. Daily soluble aspirin and prevention of colorectal adenoma recurrence: one-year results of the APACC trial[J]. Gastroenterology, 2003; 125(2):328-336.
|
16. |
[15]Steinbach G, Lynch PM, Phillips RK, Wallace MH, Hawk E, Gordon GB, Wakabayashi N, Saunders B, Shen Y, Fujimura T, Su LK, Levin B.The effect of celecoxib, a cyclooxygenase-2 inhibitor, in familial adenomatous polyposis[J]. N Engl J Med, 2000; 342 (26):1946-1952.
|
17. |
[16]Giardiello FM, Yang VW, Hylind LM, Krush AJ, Petersen GM, Trimbath JD, Piantadosi S, Garrett E, Geiman DE, Hubbard W, Offerhaus GJ, Hamilton SR. Primary Chemoprevention of Familial Adenomatous Polyposis with Sulindac[J]. N Engl J Med, 2002; 346(14):1054-1059.
|
18. |
[17]Ladenheim J, Garcia G, Titzer D, Herzenberg H, Lavori P, Edson R, Omary MB. Effect of sulindac on sporadic colonic polyps[J]. Gastroenterology,1995; 108(4):1083-1087.
|
19. |
[18]Chen HP, Han SX, Zeng LM, Xu G, Yang H. Sulindac for treatment of colorectal adenomas[J]. Chin J Dig, 2001; 21(5):340-341.
|
20. |
陈和平,韩盛玺,曾利明,徐刚,杨红. 舒林酸对散发性结肠腺瘤性息肉的疗效[J]. 中华消化杂志, 2001; 21(5):340~341.
|
21. |
[19]Nugent KP, Farmer KC, Spigelman AD, Williams CB, Phillips RK. Randomized controlled trial of effect of sulindac on duodenal and rectal polyposis and cell proliferationa in patients with familial adenomatous polyposis[J]. Br J surg, 1993; 80(12): 1618-1619.
|
22. |
[20]Gann PH, Manson JE, Glynn RJ, Buring JE, Hennekens CH. Low-dose aspirin and incidence of colorectal tumors in a randomized trial[J]. Journal of the National Cancer Institute, 1993; 85(15):1220-1224.
|
23. |
[21]Taketo MM. Cyclooxygenasa-2 inhibitor in tumorigenesis[J]. J Natl Cancer Inst, 1998; 90:1529-1536.
|
24. |
[22]Giovannucci E, Egan KM, Hunter DJ, Stampfer MJ, Colditz GA, Willett WC, Speizer FE. Aspirin and the risk of colorectal Cancer in women[J]. N Engl J Med, 1995; 333 (10):609-614.
|
25. |
[23]Derry S, Loke Yk. Risk of gastrointestinal haemorrhage with long term use of aspirin: Meta-analysis[J]. BMJ, 2000; 321: (7270):1183-1187.
|
26. |
[24]Watson AJ. Are proximal colorectal cancers always associated with distal adenomas[J]? Gut, 2003; 52(3):317-318.
|
27. |
[25]Bond JH. Polyp guideline: diagnosis, treatment, and surveillance for patients with colorectal polyps[J]. The American Journal of Gastroenterology, 2000; 95(11):3053-3063.
|